News Room

9

Mar 17

Agilent Technologies Receives 2017 Scientists' Choice Award for Best New Separation Product Agilent Technologies Inc. (NYSE: A) has received a...

Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma
05-Jun-2026, Agilent Dako
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma
26-Mar-2026, Agilent Dako
Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions
09-Mar-2026, Agilent Dako
Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications
10-Mar-2025, Agilent Dako
World Cancer Day 2025 How Agilent is Driving Advanced Cancer Diagnostics
04-Feb-2025, Agilent Dako
Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification
10-Dec-2024, Agilent Dako
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
14-Nov-2023, Agilent Dako
Agilent Receives European IVDR Certification for Companion Diagnostic Assay
24-Aug-2023, Agilent Dako
Agilent Inaugurates First Integrated Biology Center at Monash University in Malaysia
07-Aug-2023, Agilent Dako
Agilent Announces Gen6 Software for BioTek Line of Microplate Readers
10-Jul-2023, Agilent Dako

---------------------

Connect with Meximp